Abstracts tagged "radiology and takayasu arteritis"

Abstract Number: 825 • 2017 ACR/ARHP Annual Meeting
Radiological Disease Activity Is the Major Determinant for Physicians While Deciding Active Disease in Takayasu Arteritis
Gokce Kenar¹, Sedanur Karaman², Pinar Cetin³, Handan Yarkan⁴, Berrin Zengin¹, Gercek Can¹, Merih Birlik⁵ and Fatos Onen¹, ¹Rheumatology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey, ²Internal Medicine, Dokuz Eylul Universty, izmir, Turkey, ³Rheumatology, Dumlupınar University School of Medicine, Kutahya, Turkey, ⁴Rheumatology, Dokuz Eylul University Faculty of Medicine, İzmir, Turkey, ⁵Rheumatology, Dokuz Eylul University Faculty of Medicine, izmir, Turkey
Background/Purpose:There are no valid followup parameters in the assessment of disease activity in Takayasu arteritis(TA).We investigated the impact of incorporation of vascular imaging into ITAS…
Abstract Number: 3060 • 2015 ACR/ARHP Annual Meeting
The Assessment of Disease Activity in Takayasu Arteritis; Six Years Experience from a Single Center
Handan Yarkan¹, Sedanur Karaman², Pinar Cetin¹, Servet Akar³, Aytac Gulcu⁴, Ahmet Yigit Goktay⁴, Gercek Can¹, Merih Birlik¹, Nurullah Akkoc⁵ and Fatos Onen¹, ¹Rheumatology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey, ²Dokuz Eylul University Faculty of Medicine, Izmir, Turkey, ³Department of Internal Medicine, Division of Rheumatology, Izmir Katip Celebi University School of Medicine, Izmir, Turkey, ⁴Radiology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey, ⁵Department of Rheumatology, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey
Background/Purpose: The aim of this study is to analyze the activity parameters that affect the physicians global opinion (PGO) in TA. Methods: The data of…
Abstract Number: 3069 • 2015 ACR/ARHP Annual Meeting
Long Term Follow-up Results of Endovascular Repair in the Management of Arterial Stenosis Caused By Takayasu Arteritis
Aytac Gulcu¹, Naciye Sinem Gezer¹, Pinar Cetin², Servet Akar³, Nurullah Akkoc⁴, Ahmet Yigit Goktay¹ and Fatos Onen², ¹Radiology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey, ²Rheumatology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey, ³Department of Internal Medicine, Division of Rheumatology, Izmir Katip Celebi University School of Medicine, Izmir, Turkey, ⁴Department of Rheumatology, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey
Background/Purpose: Takayasu arteritis (TA) is a chronic arteritis of the aorta and its major branches. Patients may require endovascular repair in long term follow up.…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].